Translational research drives the evolution of new drugs and devices from in-vitro and bench studies through animal studies and Phase 1-1V trials and impacts quality and longevity of life and ultimately the health and productivity of communities and nations. This journey of discovery and innovation is rapidly transforming the concept of Personalized Medicine into a core 21st century reality and a key patient expectation. From genome wide association studies leading to disease prediction and prevention , genomics, proteomics and metabolomics now drives pharmacogenomics, incorporating targeted drugs and biologics development and delivery
Read More
Read More
